Due to the androgen-dependency and the crucial role of the androgen receptor (AR) in PCa progression, androgen deprivation therapy (ADT) has been denoted as the mainstay therapy for relapsed or metastatic patients [2]. This evidence concerns the gene AR and posterior cortical atrophy.